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BACKGROUND AND IMPORTANCE: Low-grade insular gliomas remain challenging
tumors for aggressive resection because of the numerous functional and vascular structures surrounding them. Because of the potential morbidities associated with open
surgical resection, less invasive techniques may confer a more optimal balance between
cytoreduction and surgical complications. For this reason, we evaluated the use of laser
interstitial thermal therapy (LITT) for resection of a dominant hemisphere oligodendroglioma World Health Organization (WHO) grade II in a 68-yr-old patient by use of
multiple staged surgeries for its resection.
CLINICAL PRESENTATION: Patient KK was a 68-yr-old female who was found to have a
large, left-sided insular mass that was shown to be an oligodendroglioma WHO grade II,
positive for codeletion 1p/19q and IDH1 mutant on biopsy. Over the course of 3 mo, KK
underwent 2 stages of LITT, targeting different areas of the 5-cm tumor. The 60-d magnetic
resonance imaging (MRI) demonstrated a reduction in size of the tumor from 5.2 × 3.3 ×
2.4 cm to 3.6 × 1.9 × 1.4 cm. She returned for a second stage targeting the anterior portion
of the tumor. KK did well postoperatively and went on to postsurgical chemoradiation. At
the 2-yr follow-up, the lesion showed near resolution on MRI.
CONCLUSION: This case report demonstrates successful use of LITT for staged surgeries to
treat a left hemisphere-dominant insular lesion. This establishes the use of LITT as a viable,
minimally invasive option to treat tumors that are difficult to access or pose concerns for
increased morbidity through an open surgery.
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L

ow-grade insular gliomas remain
challenging tumors for aggressive resection
because of the numerous functional and
vascular structures surrounding them.1 For
this reason, the Berger-Sanai insular glioma
classification system was designed to help
classify tumor types that may benefit from
more aggressive surgery, depending on their
location and size.2 More aggressive open surgical
resection, however, may increase the risk for
deficits in language, cognition, memory, affect,
and sensation, such as olfaction/taste.1-4 Because
of the potential morbidities associated with
open surgical resection, less invasive techniques
ABBREVIATIONS: FLAIR, fluid-attenuated inversion
recovery; LITT, laser interstitial thermal therapy;
MRI, magnetic resonance imaging; RSN, restingstate network; WHO, World Health Organization
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may confer a more optimal balance between
cytoreduction and surgical complications.
Specifically, laser interstitial thermal therapy
(LITT) using the NeuroBlate system (Monteris
Medical) provides minimally invasive access,
thus sparing surrounding healthy tissue, while
performing focused and precise ablation of the
targeted pathology. The NeuroBlate system
employs a 3-mm diameter, CO2 -cooled laser
that can treat 1 to 2 cm of tissue surrounding
the probe. This has been used successfully for
the treatment of high-grade gliomas, metastatic
lesions, and epilepsy in difficult-to-access areas of
the brain.5-9 Typically, these lesions are treated in
a single operation. Lesion volume with diameters
of 3 cm or greater may require multiple trajectories to treat the entire target. These large
volumes, however, are associated with higher
risk of surgical complications (eg, symptomatic
edema and seizures).9 Given the slow growing
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FIGURE 1. Language localization surrounding left oligodendroglioma in coronal A and axial B plane.

nature of low-grade gliomas and the minimally invasive nature
of LITT, we have employed a novel staged approach to treat
a select patient with large, low-grade insular glioma. Thus,
the patient trades off a single, higher-risk surgery for multiple,
lower-risk procedures. This case report, with consent from the
patient, describes the use of multiple staged LITT therapies to
treat a left-sided insular oligodendroglioma with no permanent
clinical deficit and near resolution of the tumor on postoperative
magnetic resonance imaging (MRI).
CLINICAL PRESENTATION
The patient is a 68-yr-old female (KK) who initially presented
to her primary doctor with an episode of right hand twitching
and eventually progressing to altered mental status. An MRI
performed demonstrated left-sided insular mass, approximately
5 cm in maximal dimension, nestled within language regions
demonstrated on functional MRI imaging (Figure 1). She subsequently underwent a biopsy at an outside hospital, and pathology
was an oligodendroglioma World Health Organization grade II,
positive for codeletion 1p/19q and IDH1 mutant. Although open
surgery was discussed, she did not feel comfortable and opted for
a more minimally invasive treatment. Therefore, she was offered
staged laser ablation of the insular mass.
To identify the language network, an advanced brain MRI
was obtained as described in Mitchell et al, 2013 and Leuthardt
et al, 2018.10-12 Briefly, the topography of resting-state networks
(RSNs) in individual patients is defined using a multilayer
perceptron that is trained to assign RSN membership (eg, motor,
language, and vision) to each brain voxel on the basis of resting
state functional MRI correlations.11 This method is not specific
for stimulation loci that produce speech arrest, but it is highly
sensitive, identifying eloquent speech areas that should be avoided
during surgical planning. Thus, if the tumor is far from the
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“language” RSN map, the data show that it is extremely unlikely
that awake stimulation mapping would have yielded a positive
result that would alter the surgical plan.
Using StealthStation navigation (Medtronic, Minnesota), the
first stage of the procedure targeted the posterior half of the
tumor. Using intraoperative MRI, the location of the laser
probe was verified prior to each staged treatment (Figure 2).
Treatment of the tumor progressed until the thermal dosage
thresholds maximally covered the area of interest, while avoiding
nonpathologic and functional regions of the brain. Postoperatively, she tolerated the procedure well and was observed in
the intensive care unit overnight. Having no deficits following
her laser ablation, she was discharged to home on postoperative
day 1.
KK followed up in clinic 1 wk after the ablative procedure.
At that time, she had mild difficulty with word repetition.
She returned for her 60-d MRI prior to her second stage
procedure. At this time, the left insular mass was reduced in
size, now 3.6 × 1.9 × 1.4 cm compared to the preoperative
size of 5.23 × .3 × 2.4 cm (Figure 3A-3F). Clinically, she
was back to her neurologic baseline. The amount of vasogenic
edema was also reduced. Three months later, KK returned for
the second stage of treatment. The second ablative procedure
used a trajectory that encompassed the anterior portion of the
insular glioma and its extension into the anterior temporal lobe,
paying special attention to avoid the branches of the middle
cerebral artery. Again, the procedure was tolerated well. She
had mild expressive aphasia postoperatively, which eventually
resolved after a 2-wk steroid taper. The patient’s fluid-attenuated
inversion recovery (FLAIR) signal continued to reduce at the 60-d
postprocedure MRI (Figure 3G-3I). She then went on to have
concurrent chemoradiation with temozolomide at 75 mg/m2 ,
followed by 6 cycles of high-dose adjuvant temozolomide. At
2 yr follow-up, she had near resolution of the initial FLAIR
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FIGURE 2. Coronal A and C and sagittal B and D localizer images demonstrating the location of laser probe for stage I A and B and
stage II C and D ablation treatments.

signal, which neuroradiology believed to be post-treatment effects
(Figure 3J-3L). To analyze the treatment volumes, tumor and
treatment models were created using StealthStation software. The
tumor prior to treatment had a volume of 40 cm3 , and the
initial treatment trajectory treated a volume of about 10 cm3
(Figure 4A-4C). The volume of the tumor at the start of the
second treatment was about 28 cm3 (Figure 4D-4F). The second
treatment trajectory had a larger treatment volume than the first
treatment, treating about 20 cm3 . At the 2-yr follow-up, the
residual hyperintensity volume was around 5 cm3 (Figure 4G-4I),
which was stable over 3 MRIs spanning 18 mo since the initial
follow-up.
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DISCUSSION
This case represents the confluence of a new way of thinking
about low-grade insular gliomas and about LITT. Typically,
insular tumors are considered through the lens of open surgical
resection.2 LITT therapies have historically been performed as a
single procedure for a given pathology.9 This case demonstrates
a good clinical outcome can be achieved with a slow growing
larger lesion, which may be less risky than a single, upfront
open craniotomy or a single laser procedure (with multiple
trajectories) treating a large volume. By performing multiple,
staged, well-tolerated single trajectory LITT procedures with
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FIGURE 3. FLAIR, T1 with, and T1 without images demonstrating treatment of left insular oligodendroglioma. Lesion size and FLAIR signal noticeably reduce in
size from preoperation A-C, 60 d after stage I ablation D-F, 60 d after stage II ablation G-I, and 2 yr after stage II ablation J-L.

more moderate volumes (<3 cm in diameter), the surgeon can
take a modular approach that could be less morbid for the
patients with comparable cytoreduction accomplished with a
craniotomy.
Insular lesions, particularly in the dominant hemisphere, have
increased complexity with surgical resection because of the
functional anatomy in proximity to these lesions. By staging
the procedures, the patient was allowed time between sessions
to evaluate the treatment effect, as well as modifications to the
plan and treatment aggressiveness. Using different trajectories,
each staged surgery allowed for a new area to be targeted, as
well as additional treatments to the already-treated areas, thus
maximizing the cytoreduction. Moreover, gliomas necessarily
are diffusely infiltrating and even with optimal resection, will
most likely recur. Therefore, alternatives that provide successful
cytoreduction with limited invasiveness and surgical foot print
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may provide benefit for tumors when possibility of a need for
retreatment is high.
It is important to note, however, although the described
approach has numerous potential benefits in the treatment
of insular low-grade gliomas, it will be important to further
validate this surgical strategy in the form of larger clinical
experience and outcome assessments. The use of advanced brain
imaging identifying neural networks involved in speech has
been reliably and successfully used at our institution, allowing
for use of the minimally invasive approach in specific cases.
However, depending on the location of the tumor, performing an
awake craniotomy may be necessary, and this minimally invasive
approach would not be a viable option if language mapping
was essential for increasing the safety of the tumor resection.
Therefore, LITT therapy should continue to be used in a caseby-case basis.
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FIGURE 4. Volumetric analysis using StealthStation neuronavigation software. Coronal, axial, and sagittal images demonstrating the initial tumor volume (blue
line; ∼40 cm3 ) and the first staged treatment volume (pink line; ∼10 cm3 ) A-C. Images D-F demonstrate the tumor volume at the start of the second treatment
(green line; ∼28 cm3 ) and the second stage treatment volume (orange line; ∼20 cm3 ). The volume of the residual at the 2-yr follow-up was stable over 18 mo (red
line; ∼5 cm3 ) G-I.
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CONCLUSION
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treat a patient with left insular glioma with multiple staged treatments. The treatments were well tolerated, and side effects that
were encountered resolved during the routine follow-up period.
Stereotactic laser therapy can be considered as an alternative for
insular tumors in appropriately selected patients.
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aser ablation is a novel treatment modality being used more and more
in neuro-oncology as well as epilepsy surgery. As a minimally invasive
cytoreductive treatment, it has a big advantage over open craniotomy in
the setting of recurrent and postradiated cases because of its minimal
wound healing issues compared with large incisions. In addition, it
has been used as initial treatment for a number of intracranial tumors,
including high-grade glioma. However, in most of the cases, its usage
is limited to smaller tumors. In the case of large tumors, because of
increased edema and temporary worsening mass effect, its role is limited
to combined cases with surgery.
This is a very well-written paper; it describes successful treatment
of a large insular tumor by laser interstitial thermal therapy. In this
case report, which is the very first one of its kind, staged laser ablation
has been used to minimize increased mass effect associated with laser
ablation in the early postoperative period. Especially in such a highly
eloquent area, because open surgery has its own risks and limitations,
using a minimally invasive procedure like laser ablation has a potential
advantage in treatment planning. Several cases of successful laser ablation
for smaller insular lesions had been reported before, and with this
technique of staged ablation, size would not be a major issue for selecting
patients.
Alireza Mohammadi
Cleveland, Ohio
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